Breakthrough Accelerated HBV Vaccination Surpasses Standard Regimen for CKD Patients
17 Jan 2024 • In patients with advanced CKD, an accelerated HBV vaccination regimen demonstrated a significantly higher seroconversion rate at 12 weeks of vaccination.
- A study comparing standard and accelerated HBV vaccination schedules in CKD patients, with eGFR<30 mL/min/1.73 m2 & including those on dialysis, revealed that the accelerated regimen led to a significantly higher seroconversion rate at 12 weeks.
- This demonstrated its effectiveness in achieving rapid seroconversion, a critical need for CKD patients approaching hemodialysis or kidney transplantation.
Source: Kidney International Reports | Read full story